Medinno
Developer of cell therapeutics designed to cure degenerative brain diseases such as stroke and Alzheimer's disease. The company's therapy leverages technology to cure a variety of diseases like hypoxi...
Valuation
—
Share Price
N/A
Total Raised
$31.3M
Last Round
N/A
8 investors — free account required
Sign up free Investors
+8 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details